Reynolds subsidiary is partner in creating experimental drug to treat Ebola
Story Date: 9/21/2015

 

Source: NEWS & RECORD, 9/17/15

An experimental drug produced in a partnership by a Reynolds American Inc. subsidiary said Thursday it has received a Food and Drug Administration fast-track designation for treating the Ebola virus.

For more of this story, click here.
























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our Terms of Use Agreement and our Privacy Policy.